Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nejat Altintas (Samsun, Turkey), Aziz Gumus, Nejat Altintas, Halit Cinarka, Aynur Kirbas, Muge Haziroglu, Mevlut Karatas, Unal Sahin. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD. Eur Respir J 2015; 46: Suppl. 59, 3983

Member's Comments

No comment yet.

Related content which might interest you: Soluble urokinase-type plasminogen activator receptor in monitoring of treatment response in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in exacerbated COPD Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Role of matrix metalloproteinase in predicting of COPD stability Source: International Congress 2015 – COPD: notable points Year: 2015 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Soluble urokinase plasminogen activator receptor (suPAR) is associated with COPD readmission and mortality Source: International Congress 2019 – Long-term lung function: from early birth to adulthood Year: 2019 Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) as a possible biomarker for lung cancer and/or COPD Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 SERPINE1 -675 4G/5G polymorphism is associated with asthma severity and inhaled corticosteroid response Source: Eur Respir J 2011; 38: 1036-1043 Year: 2011 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Prognostic value of urokinase plasminogen activator receptor (uPAR) and neutrophil CD64 expression in acute respiratory distress syndrome patients Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013 Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Role of activated complement in COPD exacerbation recovery Source: International Congress 2014 – Comorbidities Year: 2014 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Serum periostin in patients hospitalized for COPD exacerbations Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Soluble urokinase plasminogen activator receptor (suPAR) predicts hospital readmissions and all-cause mortality in patients admitted with asthma Source: International Congress 2019 – Long-term lung function: from early birth to adulthood Year: 2019 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014